April 27, 2021

Asthma continues to be a pervasive epidemic in the United States that disproportionately affects Black and Brown individuals in terms of incidence as well as morbidity and mortality. These disparities may, in part, be due to ancestry. Genetic markers, for example, have shown associations between African ancestry and lower lung function. However, it is also well...

Researchers are seeking to understand the variances in the use of bevacizumab and ranibizumab for the treatment of wet age-related macular degeneration (AMD) among Medicare beneficiaries. This retrospective cohort study was performed using a sample from a three-year span of 100% Medicare claims data. The data were analyzed to determine whether ranibizumab or bevacizumab was administered...

In this study, the researchers sought to determine the features of age-related macular degeneration (AMD) in the Black Barbadian population. A random group of Barbados-born citizens 40 to 84 years of age was selected. A total of 3,444 participants completed examinations at the study site and had gradable macular photographs taken of both eyes. Data were...

Healthcare professionals have cited that delayed treatment and non-continuation of treatment are concerning issues affecting wet age-related macular degeneration (AMD). Multiple factors can present barriers for patients to receive the proper diagnosis and treatment. It is imperative that individuals with AMD are diagnosed in the early stages of the disease and follow a professionally advised...

A number of new treatments for age-related macular degeneration (AMD), a progressive eye disease, are under development. AMD is a leading cause of vision loss in older people. About 11 million Americans have AMD, which affects part of the eye that allows you to see fine detail. There are two types: wet and dry. Wet...